Which drug is commonly considered the first-line pharmacologic treatment for PTSD?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

Which drug is commonly considered the first-line pharmacologic treatment for PTSD?

SSRIs are the preferred pharmacologic treatment for PTSD because they consistently reduce core symptoms like intrusive thoughts, hyperarousal, and avoidance by modulating brain circuits involved in fear learning and memory. Paroxetine stands out as a commonly chosen first-line option because it has the strongest trial evidence and is specifically approved for PTSD, showing meaningful improvements across core symptoms and related sleep disturbances. While sertraline is also a well-supported first-line agent with PTSD approval, paroxetine is often highlighted in guidelines due to its robust data base. Fluoxetine and citalopram can be effective but have less PTSD-specific evidence or safety considerations in this context, making them less likely to be the default first-line choice.

SSRIs are the preferred pharmacologic treatment for PTSD because they consistently reduce core symptoms like intrusive thoughts, hyperarousal, and avoidance by modulating brain circuits involved in fear learning and memory. Paroxetine stands out as a commonly chosen first-line option because it has the strongest trial evidence and is specifically approved for PTSD, showing meaningful improvements across core symptoms and related sleep disturbances. While sertraline is also a well-supported first-line agent with PTSD approval, paroxetine is often highlighted in guidelines due to its robust data base. Fluoxetine and citalopram can be effective but have less PTSD-specific evidence or safety considerations in this context, making them less likely to be the default first-line choice.

More practice questions